Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-30

Clinical Trial Update: Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60 [Phase 1]

View source ↗

Summary

Phase 1 trial update on decitabine with physical conditioning for newly diagnosed acute myeloid leukemia patients aged 60 and older. The study status is termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dacogen (decitabine)

Snippet

Sponsor: Emory University | Conditions: Leukemia | Phase 1 | Status: TERMINATED